COVID-19 Outpatient Therapeutics Clinical Decision Aid

September 2023

Clinical Decision Aid for Ages 12+ years

Adult or pediatric patients (ages 12 and older* weighing at least 40 kg) with mild to moderate COVID-19 and at high risk for progression to severe disease
*Age requirement does not apply for Veklury (remdesivir)

Clinical Decision Aid for Ages 12+ years Infographic

^1.NIH COVID-19 Treatment Guidelines Therapeutic Management of Nonhospitalized Adults With COVID-19.
^2.Paxlovid EUA.
^3.NIH’s COVID-19 Treatment Guidelines Panel: Ritonavir-Boosted Nirmatrelvir (Paxlovid).
^4.Veklury (remdesivir) Prescribing Information.
^5.Lagevrio EUA.
^6.CDC COVID-19 Website
^7.Fact Sheet for Health Care Providers: EUA of COVID-19 Convalescent Plasma for Treatment of COVID-19.

Clinical Decision Aid for Pediatric patients 28 days of Age and Older

Pediatric patients 28 days of age and older weighing 3 kg to less than 40 kg with mild to moderate COVID-19 and at high risk for progression to severe disease

Clinical Decision Aid: Pediatric patients 28 days of age and older weighing 3 kg to less than 40 kg with mild to moderate COVID-19 and at high risk for progression to severe disease infographic

^1.Veklury Prescribing Information.
^2.NIH COVID-19 Treatment Guidelines Therapeutic Management of Nonhospitalized Adults With COVID-19.
^3.CDC Covid-19 Website .